Date: 08/05/2025 (15:30)
Title: "Location of Lewy body pathology drives dopaminergic cell vulnerability in pigmented non-human primates"
Speaker: Julia Chocarro (Predoctoral Researcher)
Group CIBERNED: José Luis Lanciego
CIBERNED Webinar Series 2025
On 1 January 2022, the Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), was merged by absorption into the Consorcio Centro de Investigación Biomédica en Red (CIBER), continuing and giving more scope to the scientific sessions, "CIBERNED Webinar Series". The aim of this tool is to share the latest scientific advances carried out in the CIBERNED thematic area, to make different members of the groups known through their active participation, and to stimulate interactions and collaborations between all CIBER members.
In this new stage, these are no longer internal seminars, but are now open to anyone who wishes to attend, in virtual format, in English and, of course, free of charge. The sessions lasts approximately 30 minutes, followed by a question and answer session and discussion for a total time of approximately 45-60 minutes. A few days prior to the webinar, the connection link to the Teams platform is published for anyone who wishes to access it.
The webinars scheduled so far are listed below. Those recorded sessions that have been authorised by the speakers will be published on the CIBERNED YouTube channel:
Date | Speaker | Affiliation | CIBERNED Group/Institution | Title | Video/Access |
---|---|---|---|---|---|
16 JANUARY |
Yaroslau Compta (Associate Professor and Deputy Doctor) |
Unitat de Parkinson i Trastorns del Moviment del Servicio de Neurología del Hospital Clínic; IDIBAPS; Universitat de Barcelona. |
Maria Josep Martí - Program 2 | Registro PSP Barcelona - estudio multicéntrico de características clínicas, biomarcadores y educación terapéutica | Watch video |
13 FEBRUARY | Javier Fernández-Ruiz (Senior Investigator) | Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense de Madrid (UCM) | Javier Fernández-Ruiz - Program 1 | Desarrollo hacia la clínica de un agonista del receptor cannabinoide CB2 como terapia neuroprotectora en la esclerosis lateral amiotrófica | Watch video |
27 FEBRUARY | Laura Modol (Ramón y Cajal Investigator) | Fundación Hospital del Mar Research Institute, Parc de Recerca Biomèdica de Barcelona (PRBB) | Xavier Navarro - Program 3 | Cell-type specific modulation of brain developmental dynamics | Watch Video |
13 MARCH | Javier Pagonabarraga (Neurologist) |
Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital Sant Pau, Barcelona; Institut de Recerca Biomèdica de l'Hospital Sant Pau; Universitat Autònoma de Barcelona |
Jaime Kulisevsky - Program 2 | Technological journey into the neurobiology of hallucinations and consciousness in Parkinson's Disease | Watch video |
27 MARCH | Rodrigo Pacheco (Senior Investigator) | Laboratorio de Neuroinmunología, Centro Científico y Tecnológico de Excelencia Ciencia & Vida; Fundación Ciencia & Vida, Santiago, Chile; Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile. | Invited guest | Engineered T cell therapy for Parkinson's disease | Watch video |
10 APRIL | Mercè Masana (Associate Professor) | Dept. Biomedical Sciences, Institute of Neurosciences, School of Medicine and Health Sciences, Universitat de Barcelona. | Jordi Alberch - Program 2 | Moving beyond the striatum: how cortical circuits modulate motor and sensory symptoms in Huntington's Disease | Access to the webinar |
24 APRIL |
Lorea Blázquez (Ramón y Cajal and Ikerbasque Researcher) |
Neurogenetics, RNA biology and therapies; Neurosciences Area Biogipuzkoa Health Research Institute |
Aldolfo López de Munain - Program 3 | Targeting RNA-misprocessing in neurological disorders with antisense oligonucleotides and beyond | Access to the webinar |
8 MAY | Julia Chocarro (Predoctoral Researcher) | CNS Gene Therapy Program, Centro de Investigación Médica Aplicada, University of Navarra | José Luis Lanciego - Program 2 | Location of Lewy body pathology drives dopaminergic cell vulnerability in pigmented non-human primates | |
22 MAY | José Luis Lanciego (Senior Scientist) |
CNS Gene Therapy Program, Center for Applied Medical Research (Cima), University of Navarra. |
José Luis Lanciego | Introducing PIGMO, a novel PIGmented Mouse model of Parkinson's disease | Watch video |
5 JUNE |
Patricia Regina Manzine (Marie Skłodowska-Curie Postdoctoral researcher) |
Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Universitat de Barcelona and Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) Membership Laboratory of Biology of Aging - LABEN, UFSCar São Carlos - SP, Brazil |
Antonio Camins - Program 1 | La asociación de ADAM10 y otros biomarcadores proteicos en la sangre: potencial para diferenciar tipos de demencia. | Access to the webinar |
19 JUNE | Inmaculada Cuchillo (Profesora Ayudante Doctor) |
Universidad Miguel Hernández de Elche, Instituto de Neurociencias de Alicante |
Javier Sáez - Program 1 | Glicosilación de la apolipoproteína apoE en la corteza y líquido cefalorraquídeo en el Alzheimer | Access to the webinar |
3 JULY |
Alexandre Bejanin (Miguel Servet Researcher) |
Sant Pau Memory Unit, Institut de Recerca Sant Pau - Centre CERCA, Barcelona | Alberto Lleó - Program 1 | Neuroimaging of Alzheimer's and vascular pathologies in Down syndrome | Access to the webinar |
17 JULY | Jose V. Sanchez-Mut (Senior Investigator) | Laboratorio de Epi-Genómica Funcional del Envejecimiento y la Enfermedad de Alzheimer, Dpto. Neurobiología Molecular y Neuropatología, Instituto de Neurociencias de Alicante (UMH-CSIC) | Invited guest | Functional epi-genomics unveils new therapeutic opportunities for Alzheimer's disease | Access to the webinar |